- Home
- Publications
- Publication Search
- Publication Details
Title
The Breast Cancer Stem Cells Traits and Drug Resistance
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-01-28
DOI
10.3389/fphar.2020.599965
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Effect of a Newly Synthesized Ferrocene Derivative AGAINST MCF-7 Breast Cancer Cells and Spheroid Stem Cells through ROS Production and Inhibition of JAK2/STAT3 Signaling Pathway
- (2020) Mitra Nourbakhsh et al. Anti-Cancer Agents in Medicinal Chemistry
- Salinomycin Derivatives Kill Breast Cancer Stem Cells via Lysosomal Iron Targeting
- (2020) Antoine Versini et al. CHEMISTRY-A EUROPEAN JOURNAL
- Deficiency in Dipeptidyl Peptidase-4 Promotes Chemoresistance Through the CXCL12/CXCR4/mTOR/TGFβ Signaling Pathway in Breast Cancer Cells
- (2020) Shaolan Li et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Modulation of ABCG2 surface expression by Rab5 and Rab21 to overcome multidrug resistance in cancer cells
- (2020) Maryam Yousaf et al. XENOBIOTICA
- Phenethyl Isothiocyanate Suppresses Stemness in the Chemo- and Radio-Resistant Triple-Negative Breast Cancer Cell Line MDA-MB-231/IR Via Downregulation of Metadherin
- (2020) Yen Thi-Kim Nguyen et al. Cancers
- CD44 Targeting Mediated by Polymeric Nanoparticles and Combination of Chlorine TPCS2a-PDT and Docetaxel-Chemotherapy for Efficient Killing of Breast Differentiated and Stem Cancer Cells In Vitro
- (2020) Elisa Gaio et al. Cancers
- DNA damage response and resistance of cancer stem cells
- (2020) Etna Abad et al. CANCER LETTERS
- Emerging Antineoplastic Biogenic Gold Nanomaterials for Breast Cancer Therapeutics: A Systematic Review
- (2020) Muthupandian Saravanan et al. International Journal of Nanomedicine
- MK-2206 and Standard Neoadjuvant Chemotherapy Improves Response in Patients With Human Epidermal Growth Factor Receptor 2–Positive and/or Hormone Receptor–Negative Breast Cancers in the I-SPY 2 Trial
- (2020) A. Jo Chien et al. JOURNAL OF CLINICAL ONCOLOGY
- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Emerging Theranostic Biogenic Silver Nanomaterials for Breast Cancer: A Systematic Review
- (2019) Hamed Barabadi et al. JOURNAL OF CLUSTER SCIENCE
- Cancer stem-like properties of hormonal therapy-resistant breast cancer cells
- (2019) Kanami Uchiumi et al. Breast Cancer
- Everolimus Reverses Palbociclib Resistance in ER+ Human Breast Cancer Cells by Inhibiting Phosphatidylinositol 3-Kinase(PI3K)/Akt/Mammalian Target of Rapamycin (mTOR) Pathway
- (2019) Lin Chen et al. MEDICAL SCIENCE MONITOR
- Genetic Epidemiology of Breast Cancer in Latin America
- (2019) Valentina A. Zavala et al. Genes
- Blocking CXCR4 alleviates desmoplasia, increases T-lymphocyte infiltration, and improves immunotherapy in metastatic breast cancer
- (2019) Ivy X. Chen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Combined inhibition of STAT3 and DNA repair in palbociclib-resistant ER-positive breast cancer
- (2019) Nicole M. Kettner et al. CLINICAL CANCER RESEARCH
- Spleen tyrosine kinase-mediated autophagy is required for epithelial-mesenchymal plasticity and metastasis in breast cancer
- (2019) Aparna Shinde et al. CANCER RESEARCH
- Oxidative stress induces senescence in breast cancer stem cells
- (2019) Guangxian Zhong et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Disulfiram modulates ROS accumulation and overcomes synergistically cisplatin resistance in breast cancer cell lines
- (2019) Zhi Yang et al. BIOMEDICINE & PHARMACOTHERAPY
- Emerging Theranostic Silver and Gold Nanomaterials to Combat Prostate Cancer: A Systematic Review
- (2019) Hamed Barabadi et al. JOURNAL OF CLUSTER SCIENCE
- Breast Cancer Tumor Stroma: Cellular Components, Phenotypic Heterogeneity, Intercellular Communication, Prognostic Implications and Therapeutic Opportunities
- (2019) Eiro et al. Cancers
- Metabolic activation triggered by cAMP in MCF-7 cells generates lethal vulnerability to combined oxamate/etomoxir
- (2019) Marcella Manerba et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- MiR-124 reversed the doxorubicin resistance of breast cancer stem cells through STAT3/HIF-1 signaling pathways
- (2019) Cong Liu et al. CELL CYCLE
- Expanding the Biotherapeutics Realm via miR-34a: “Potent Clever Little” Agent in Breast Cancer Therapy
- (2019) Mohsen Mohammady et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- GPER‐induced signaling is essential for the survival of breast cancer stem cells
- (2019) Yu‐Tzu Chan et al. INTERNATIONAL JOURNAL OF CANCER
- EIF2A promotes cell survival during paclitaxel treatment in vitro and in vivo
- (2019) Lin Chen et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Recombinant human PRG4 (rhPRG4) suppresses breast cancer cell invasion by inhibiting TGFβ-Hyaluronan-CD44 signalling pathway
- (2019) Anusi Sarkar et al. PLoS One
- Metabolic and non-metabolic pathways that control cancer resistance to anthracyclines
- (2019) Tânia Capelôa et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- The Central Contributions of Breast Cancer Stem Cells in Developing Resistance to Endocrine Therapy in Estrogen Receptor (ER)-Positive Breast Cancer
- (2019) David Rodriguez et al. Cancers
- Matrix Hyaluronan-CD44 Interaction Activates MicroRNA and LncRNA Signaling Associated With Chemoresistance, Invasion, and Tumor Progression
- (2019) Lilly Y. W. Bourguignon Frontiers in Oncology
- CDK 12 drives breast tumor initiation and trastuzumab resistance via WNT and IRS 1‐ErbB‐ PI 3K signaling
- (2019) Hee‐Joo Choi et al. EMBO REPORTS
- Emerging Theranostic Silver Nanomaterials to Combat Colorectal Cancer: A Systematic Review
- (2019) Hamed Barabadi et al. JOURNAL OF CLUSTER SCIENCE
- Emerging Selenium Nanoparticles to Combat Cancer: a Systematic Review
- (2019) Hossein Vahidi et al. JOURNAL OF CLUSTER SCIENCE
- The FBXW2–MSX2–SOX2 axis regulates stem cell property and drug resistance of cancer cells
- (2019) Yuan Yin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Hedgehog Signaling Pathway: A Viable Target in Breast Cancer?
- (2019) Priyanka Bhateja et al. Cancers
- Gomisin M2 from Baizuan suppresses breast cancer stem cell proliferation in a zebrafish xenograft model
- (2019) Yeguo Yang et al. Aging-US
- Breast cancer statistics, 2019
- (2019) Carol E. DeSantis et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Antineoplastic Biogenic Silver Nanomaterials to Combat Cervical Cancer: A Novel Approach in Cancer Therapeutics
- (2019) Hamed Barabadi et al. JOURNAL OF CLUSTER SCIENCE
- Comparative Anticancer Potential of Biologically and Chemically Synthesized Gold Nanoparticles
- (2019) Ishita Virmani et al. JOURNAL OF CLUSTER SCIENCE
- Novel and Alternative Targets Against Breast Cancer Stemness to Combat Chemoresistance
- (2019) Sangita Sridharan et al. Frontiers in Oncology
- Functional extracellular vesicles engineered with lipid-grafted hyaluronic acid effectively reverse cancer drug resistance
- (2019) Jia Liu et al. BIOMATERIALS
- WEE1 inhibitor, AZD1775, overcomes trastuzumab resistance by targeting cancer stem-like properties in HER2-positive breast cancer
- (2019) Andrea Sand et al. CANCER LETTERS
- Nanoplatform Assembled from a CD44-Targeted Prodrug and Smart Liposomes for Dual Targeting of Tumor Microenvironment and Cancer Cells
- (2018) Yaqi Lv et al. ACS Nano
- Mutations in the estrogen receptor alpha hormone binding domain promote stem cell phenotype through notch activation in breast cancer cell lines
- (2018) L. Gelsomino et al. CANCER LETTERS
- Cancer stem cell in breast cancer therapeutic resistance
- (2018) Xupeng Bai et al. CANCER TREATMENT REVIEWS
- JAK/STAT3-Regulated Fatty Acid β-Oxidation Is Critical for Breast Cancer Stem Cell Self-Renewal and Chemoresistance
- (2018) Tianyi Wang et al. Cell Metabolism
- Salinomycin, as an autophagy modulator-- a new avenue to anticancer: a review
- (2018) Jiang Jiang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Notch-1-PTEN-ERK1/2 signaling axis promotes HER2+ breast cancer cell proliferation and stem cell survival
- (2018) Andrew Baker et al. ONCOGENE
- Stemness Phenotype in Tamoxifen Resistant Breast Cancer Cells may be induced by Interactions between Receptor Tyrosine Kinases and ERα-66
- (2018) Leila Farahmand et al. Recent Patents on Anti-Cancer Drug Discovery
- Downregulation of annexin A3 inhibits tumor metastasis and decreases drug resistance in breast cancer
- (2018) Ruikai Du et al. Cell Death & Disease
- Tumor‑derived mesenchymal‑stem‑cell‑secreted IL‑6 enhances resistance to cisplatin via the STAT3 pathway in breast cancer
- (2018) Huitao Xu et al. Oncology Letters
- Autophagy promotes the survival of dormant breast cancer cells and metastatic tumour recurrence
- (2018) Laura Vera-Ramirez et al. Nature Communications
- Targeting stromal remodeling and cancer stem cell plasticity overcomes chemoresistance in triple negative breast cancer
- (2018) Aurélie S. Cazet et al. Nature Communications
- Targeting intracellular MMPs efficiently inhibits tumor metastasis and angiogenesis
- (2018) Yaqi Lv et al. Theranostics
- Quercetin Inhibits Breast Cancer Stem Cells via Downregulation of Aldehyde Dehydrogenase 1A1 (ALDH1A1), Chemokine Receptor Type 4 (CXCR4), Mucin 1 (MUC1), and Epithelial Cell Adhesion Molecule (EpCAM)
- (2018) Rong Wang et al. MEDICAL SCIENCE MONITOR
- Taxane resistance in castration-resistant prostate cancer: mechanisms and therapeutic strategies
- (2018) Brandon Bumbaca et al. Acta Pharmaceutica Sinica B
- Targeting Breast Cancer Stem Cells to Overcome Treatment Resistance
- (2018) Sònia Palomeras et al. MOLECULES
- Glucosamine decreases the stemness of human ALDH+ breast cancer stem cells by inactivating STAT3
- (2018) Rendy Hosea et al. Oncology Letters
- BCMA (TNFRSF17) Induces APRIL and BAFF Mediated Breast Cancer Cell Stemness
- (2018) Vasiliki Pelekanou et al. Frontiers in Oncology
- Resistance of primary breast cancer cells with enhanced pluripotency and stem cell activity to sex hormonal stimulation and suppression
- (2018) Mostafa Nasr et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Molecular mechanisms of resistance to CDK4/6 inhibitors in breast cancer: A review
- (2018) Kamal Pandey et al. INTERNATIONAL JOURNAL OF CANCER
- Hypoxia‐inducible factor‐2α directly promotes BCRP expression and mediates the resistance of ovarian cancer stem cells to adriamycin
- (2018) Miao He et al. Molecular Oncology
- Doxycycline, an Inhibitor of Mitochondrial Biogenesis, Effectively Reduces Cancer Stem Cells (CSCs) in Early Breast Cancer Patients: A Clinical Pilot Study
- (2018) Cristian Scatena et al. Frontiers in Oncology
- Self-renewal signaling pathways in breast cancer stem cells
- (2018) Lakshmi Vineela Nalla et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Nanomedicine applications in the treatment of breast cancer: current state of the art
- (2017) Di Wu et al. International Journal of Nanomedicine
- CD44+ fibroblasts increases breast cancer cell survival and drug resistance via IGF2BP3-CD44-IGF2 signalling
- (2017) Yonglei Liu et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Vitamin D compounds inhibit cancer stem-like cells and induce differentiation in triple negative breast cancer
- (2017) Naing Lin Shan et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Estrogen Receptor β as a Therapeutic Target in Breast Cancer Stem Cells
- (2017) Ran Ma et al. JNCI-Journal of the National Cancer Institute
- Breast cancer
- (2017) Nadia Harbeck et al. LANCET
- Normal and cancerous mammary stem cells evade interferon-induced constraint through the miR-199a–LCOR axis
- (2017) Toni Celià-Terrassa et al. NATURE CELL BIOLOGY
- Cancer stem cells and differentiation therapy
- (2017) Xiong Jin et al. TUMOR BIOLOGY
- Anti-cell growth and anti-cancer stem cell activities of the non-canonical hedgehog inhibitor GANT61 in triple-negative breast cancer cells
- (2017) Yoshikazu Koike et al. Breast Cancer
- BAG3 promotes stem cell-like phenotype in breast cancer by upregulation of CXCR4 via interaction with its transcript
- (2017) Bao-Qin Liu et al. Cell Death & Disease
- A phase I study of the SRC kinase inhibitor dasatinib with trastuzumab and paclitaxel as first line therapy for patients with HER2-overexpressing advanced breast cancer. GEICAM/2010-04 study
- (2017) Alberto Ocana et al. Oncotarget
- Expression of embryonal stem cell transcription factors in breast cancer: Oct4 as an indicator for poor clinical outcome and tamoxifen resistance
- (2017) Jae Moon Gwak et al. Oncotarget
- Targeting autophagic cancer stem-cells to reverse chemoresistance in human triple negative breast cancer
- (2017) Guilhem Bousquet et al. Oncotarget
- Rapalogs can promote cancer cell stemness in vitro in a Galectin-1 and H-ras-dependent manner
- (2017) Itziar Posada et al. Oncotarget
- IKK inhibition by BMS-345541 suppresses breast tumorigenesis and metastases by targeting GD2+ cancer stem cells
- (2017) Venkata Lokesh Battula et al. Oncotarget
- Interaction of glycosphingolipids GD3 and GD2 with growth factor receptors maintains breast cancer stem cell phenotype
- (2017) Yuh-Jin Liang et al. Oncotarget
- Modulation of SOX2 expression delineates an end-point for paclitaxel-effectiveness in breast cancer stem cells
- (2017) Pritha Mukherjee et al. Scientific Reports
- Estrogen Receptor β as a Therapeutic Target in Breast Cancer Stem Cells
- (2017) Ran Ma et al. JNCI-Journal of the National Cancer Institute
- Targeting Signaling Pathways in Cancer Stem Cells for Cancer Treatment
- (2017) Jeffrey Koury et al. Stem Cells International
- Inhibition of KLF4 by Statins Reverses Adriamycin-Induced Metastasis and Cancer Stemness in Osteosarcoma Cells
- (2017) Yangling Li et al. Stem Cell Reports
- Treatment with the WNT5A-mimicking peptide Foxy-5 effectively reduces the metastatic spread of WNT5A-low prostate cancer cells in an orthotopic mouse model
- (2017) Giacomo Canesin et al. PLoS One
- Expression of breast cancer stem cell markers as predictors of prognosis and response to trastuzumab in HER2-positive breast cancer
- (2016) An Na Seo et al. BRITISH JOURNAL OF CANCER
- Mesenchymal stem cells exhibit resistance to topoisomerase inhibition
- (2016) Nils H. Nicolay et al. CANCER LETTERS
- The Ribonucleic Complex HuR-MALAT1 Represses CD133 Expression and Suppresses Epithelial-Mesenchymal Transition in Breast Cancer
- (2016) E. Latorre et al. CANCER RESEARCH
- High CDK6 Protects Cells from Fulvestrant-Mediated Apoptosis and is a Predictor of Resistance to Fulvestrant in Estrogen Receptor–Positive Metastatic Breast Cancer
- (2016) Carla L. Alves et al. CLINICAL CANCER RESEARCH
- CD44 targeted chemotherapy for co-eradication of breast cancer stem cells and cancer cells using polymeric nanoparticles of salinomycin and paclitaxel
- (2016) Eameema Muntimadugu et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Methylparaben stimulates tumor initiating cells in ER+ breast cancer models
- (2016) M. Angeles Lillo et al. JOURNAL OF APPLIED TOXICOLOGY
- ABCG2 inhibition as a therapeutic approach for overcoming multidrug resistance in cancer
- (2016) Maryam Hosseini Hasanabady et al. JOURNAL OF BIOSCIENCES
- ABCG2/BCRP: Specific and Nonspecific Modulators
- (2016) Diana Peña-Solórzano et al. MEDICINAL RESEARCH REVIEWS
- Cancer stem cell metabolism: a potential target for cancer therapy
- (2016) Abhijeet Deshmukh et al. Molecular Cancer
- MENA Confers Resistance to Paclitaxel in Triple-Negative Breast Cancer
- (2016) Madeleine J. Oudin et al. MOLECULAR CANCER THERAPEUTICS
- Non-migratory tumorigenic intrinsic cancer stem cells ensure breast cancer metastasis by generation of CXCR4+ migrating cancer stem cells
- (2016) S Mukherjee et al. ONCOGENE
- COX-2 Induces Breast Cancer Stem Cells via EP4/PI3K/AKT/NOTCH/WNT Axis
- (2016) Mousumi Majumder et al. STEM CELLS
- Lapatinib resistance in HER2+ cancers: latest findings and new concepts on molecular mechanisms
- (2016) Huiping Shi et al. TUMOR BIOLOGY
- Self-renewal of CD133hi cells by IL6/Notch3 signalling regulates endocrine resistance in metastatic breast cancer
- (2016) Pasquale Sansone et al. Nature Communications
- Phase I study of the gamma secretase inhibitor PF-03084014 in combination with docetaxel in patients with advanced triple-negative breast cancer
- (2016) Marzia A. Locatelli et al. Oncotarget
- ERα propelled aberrant global DNA hypermethylation by activating the DNMT1 gene to enhance anticancer drug resistance in human breast cancer cells
- (2016) Xinxin Si et al. Oncotarget
- New use of an old drug: inhibition of breast cancer stem cells by benztropine mesylate
- (2016) Jihong Cui et al. Oncotarget
- 3,6-dihydroxyflavone suppresses the epithelial-mesenchymal transition in breast cancer cells by inhibiting the Notch signaling pathway
- (2016) Junli Chen et al. Scientific Reports
- Hedgehog pathway is involved in nitidine chloride induced inhibition of epithelial-mesenchymal transition and cancer stem cells-like properties in breast cancer cells
- (2016) Mingjuan Sun et al. Cell and Bioscience
- Anticancer efficacy of the hypoxia-activated prodrug evofosfamide (TH-302) in osteolytic breast cancer murine models
- (2016) Vasilios Liapis et al. Cancer Medicine
- Enhanced efficacy of chemotherapy for breast cancer stem cells by simultaneous suppression of multidrug resistance and antiapoptotic cellular defense
- (2015) Ming Sun et al. Acta Biomaterialia
- Genome-Wide Identification and Characterization of Novel Factors Conferring Resistance to Topoisomerase II Poisons in Cancer
- (2015) R. H. Wijdeven et al. CANCER RESEARCH
- Wnt/ -Catenin Small-Molecule Inhibitor CWP232228 Preferentially Inhibits the Growth of Breast Cancer Stem-like Cells
- (2015) G.-B. Jang et al. CANCER RESEARCH
- Treatment of Triple-Negative Breast Cancer with TORC1/2 Inhibitors Sustains a Drug-Resistant and Notch-Dependent Cancer Stem Cell Population
- (2015) Neil E. Bhola et al. CANCER RESEARCH
- Therapeutic strategies targeting cancer stem cells
- (2015) Go J. Yoshida et al. CANCER SCIENCE
- Regulation of the breast cancer stem cell phenotype by hypoxia-inducible factors
- (2015) G. L. Semenza CLINICAL SCIENCE
- The Hedgehog signalling pathway mediates drug response of MCF-7 mammosphere cells in breast cancer patients
- (2015) Miao He et al. CLINICAL SCIENCE
- Factors Promoting Tamoxifen Resistance in Breast Cancer via Stimulating Breast Cancer Stem Cell Expansion
- (2015) Diane Ojo et al. CURRENT MEDICINAL CHEMISTRY
- The tumor-suppressive and potential therapeutic functions of miR-34a in epithelial carcinomas
- (2015) Brian D. Adams et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Combination therapy with epigenetic-targeted and chemotherapeutic drugs delivered by nanoparticles to enhance the chemotherapy response and overcome resistance by breast cancer stem cells
- (2015) Shi-Yong Li et al. JOURNAL OF CONTROLLED RELEASE
- Lentivirus-mediated shRNA targeting Nanog inhibits cell proliferation and attenuates cancer stem cell activities in breast cancer
- (2015) Chun Hu et al. JOURNAL OF DRUG TARGETING
- CONSORT
- (2015) Lan Wang et al. MEDICINE
- Quantum dot nanoprobe-based high-content monitoring of notch pathway inhibition of breast cancer stem cell by capsaicin
- (2015) Yumi Shim et al. MOLECULAR AND CELLULAR PROBES
- Adjuvant Ovarian Suppression in Premenopausal Breast Cancer
- (2015) Prudence A. Francis et al. NEW ENGLAND JOURNAL OF MEDICINE
- A role for cancer stem cells in therapy resistance: Cellular and molecular mechanisms
- (2015) Monica Cojoc et al. SEMINARS IN CANCER BIOLOGY
- Implications of stemness-related signaling pathways in breast cancer response to therapy
- (2015) Valentina Angeloni et al. SEMINARS IN CANCER BIOLOGY
- Cancer Stem Cell-Like Phenotype and Survival Are Coordinately Regulated by Akt/FoxO/Bim Pathway
- (2015) Ricardo Gargini et al. STEM CELLS
- Enhanced SLC34A2 in breast cancer stem cell-like cells induces chemotherapeutic resistance to doxorubicin via SLC34A2-Bmi1-ABCC5 signaling
- (2015) Guanqun Ge et al. TUMOR BIOLOGY
- miR-205-5p-mediated downregulation of ErbB/HER receptors in breast cancer stem cells results in targeted therapy resistance
- (2015) A De Cola et al. Cell Death & Disease
- Cleaved CD44 intracellular domain supports activation of stemness factors and promotes tumorigenesis of breast cancer
- (2015) Yunhee Cho et al. Oncotarget
- Cardamonin reduces chemotherapy-enriched breast cancer stem-like cells in vitro and in vivo
- (2015) Deyong Jia et al. Oncotarget
- MiR-221 promotes stemness of breast cancer cells by targeting DNMT3b
- (2015) Giuseppina Roscigno et al. Oncotarget
- Mitochondrial biogenesis is required for the anchorage-independent survival and propagation of stem-like cancer cells
- (2015) Arianna De Luca et al. Oncotarget
- EpCAM Aptamer-mediated Survivin Silencing Sensitized Cancer Stem Cells to Doxorubicin in a Breast Cancer Model
- (2015) Tao Wang et al. Theranostics
- The Rab2A GTPase Promotes Breast Cancer Stem Cells and Tumorigenesis via Erk Signaling Activation
- (2015) Man-Li Luo et al. Cell Reports
- Anti-estrogen Resistance in Human Breast Tumors Is Driven by JAG1-NOTCH4-Dependent Cancer Stem Cell Activity
- (2015) Bruno M. Simões et al. Cell Reports
- The Global Burden of Cancer 2013
- (2015) Christina Fitzmaurice et al. JAMA Oncology
- Development, Maintenance, and Reversal of Multiple Drug Resistance: At the Crossroads of TFPI1, ABC Transporters, and HIF1
- (2015) Terra Arnason et al. Cancers
- Role of the Breast Cancer Resistance Protein (BCRP/ABCG2) in Drug Transport—an Update
- (2014) Qingcheng Mao et al. AAPS Journal
- Mammary Cancer Chemoprevention by Withaferin A Is Accompanied by In Vivo Suppression of Self-Renewal of Cancer Stem Cells
- (2014) S.-H. Kim et al. Cancer Prevention Research
- PI3K/mTOR Dual Inhibitor VS-5584 Preferentially Targets Cancer Stem Cells
- (2014) V. N. Kolev et al. CANCER RESEARCH
- MicroRNA100 Inhibits Self-Renewal of Breast Cancer Stem-like Cells and Breast Tumor Development
- (2014) L. Deng et al. CANCER RESEARCH
- Expression of CD24 is associated with HER2 expression and supports HER2-Akt signaling in HER2-positive breast cancer cells
- (2014) Mari Hosonaga et al. CANCER SCIENCE
- Metastatic Stem Cells: Sources, Niches, and Vital Pathways
- (2014) Thordur Oskarsson et al. Cell Stem Cell
- Strong correlation between N-cadherin and CD133 in breast cancer: role of both markers in metastatic events
- (2014) Carolin Bock et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- NOTCH-induced aldehyde dehydrogenase 1A1 deacetylation promotes breast cancer stem cells
- (2014) Di Zhao et al. JOURNAL OF CLINICAL INVESTIGATION
- ABCG2, a novel antigen to sort luminal progenitors of BRCA1- breast cancer cells
- (2014) Felicia Leccia et al. Molecular Cancer
- Taxane-induced hedgehog signaling is linked to expansion of breast cancer stem-like populations after chemotherapy
- (2014) Jennifer Sims-Mourtada et al. MOLECULAR CARCINOGENESIS
- Quantitative phosphoproteomic analysis reveals system-wide signaling pathways downstream of SDF-1/CXCR4 in breast cancer stem cells
- (2014) T. Yi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Hypoxia-inducible factors are required for chemotherapy resistance of breast cancer stem cells
- (2014) Debangshu Samanta et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Molecular aspects of cancer cell resistance to chemotherapy
- (2013) Magali Rebucci et al. BIOCHEMICAL PHARMACOLOGY
- The Wnt signalling pathway is upregulated in an in vitro model of acquired tamoxifen resistant breast cancer
- (2013) Yan Ni Loh et al. BMC CANCER
- Clinical–pathologic significance of cancer stem cell marker expression in familial breast cancers
- (2013) Anita Bane et al. BREAST CANCER RESEARCH AND TREATMENT
- Tamoxifen selects for breast cancer cells with mammosphere forming capacity and increased growth rate
- (2013) Diego Raffo et al. BREAST CANCER RESEARCH AND TREATMENT
- Fulvestrant induces resistance by modulating GPER and CDK6 expression: implication of methyltransferases, deacetylases and the hSWI/SNF chromatin remodelling complex
- (2013) B Giessrigl et al. BRITISH JOURNAL OF CANCER
- Silencing NOTCH signaling causes growth arrest in both breast cancer stem cells and breast cancer cells
- (2013) S Suman et al. BRITISH JOURNAL OF CANCER
- ALDH1-Positive Cancer Stem Cells Predict Engraftment of Primary Breast Tumors and Are Governed by a Common Stem Cell Program
- (2013) E. Charafe-Jauffret et al. CANCER RESEARCH
- Basal/HER2 breast carcinomas
- (2013) Begoña Martin-Castillo et al. CELL CYCLE
- Reprogramming of non-genomic estrogen signaling by the stemness factor SOX2 enhances the tumor-initiating capacity of breast cancer cells
- (2013) Alejandro Vazquez-Martin et al. CELL CYCLE
- Preclinical and Clinical Studies of Gamma Secretase Inhibitors with Docetaxel on Human Breast Tumors
- (2013) A. F. Schott et al. CLINICAL CANCER RESEARCH
- Sox2 promotes tamoxifen resistance in breast cancer cells
- (2013) Marco Piva et al. EMBO Molecular Medicine
- Derailed Estrogen Signaling and Breast Cancer: An Authentic Couple
- (2013) Bramanandam Manavathi et al. ENDOCRINE REVIEWS
- Estrogen Receptor-α Variant, ER-α36, is Involved in Tamoxifen Resistance and Estrogen Hypersensitivity
- (2013) XianTian Zhang et al. ENDOCRINOLOGY
- Tamoxifen resistance: From bench to bedside
- (2013) Marjolein Droog et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- STAT3 activation in HER2-overexpressing breast cancer promotes epithelial-mesenchymal transition and cancer stem cell traits
- (2013) SEYUNG S. CHUNG et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- TGF-β inhibition enhances chemotherapy action against triple-negative breast cancer
- (2013) Neil E. Bhola et al. JOURNAL OF CLINICAL INVESTIGATION
- CD133-targeted paclitaxel delivery inhibits local tumor recurrence in a mouse model of breast cancer
- (2013) Suresh Kumar Swaminathan et al. JOURNAL OF CONTROLLED RELEASE
- Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay
- (2013) Irène Baccelli et al. NATURE BIOTECHNOLOGY
- Endothelial Protein C Receptor Function in Murine and Human Breast Cancer Development
- (2013) Florence Schaffner et al. PLoS One
- Genome-wide reprogramming of the chromatin landscape underlies endocrine therapy resistance in breast cancer
- (2013) L. Magnani et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeting CXCL12/CXCR4 signaling with oncolytic virotherapy disrupts tumor vasculature and inhibits breast cancer metastases
- (2013) M. Gil et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Everolimus in combination with letrozole inhibit human breast cancer MCF-7/Aro stem cells via PI3K/mTOR pathway: an experimental study
- (2013) Yan Liu et al. TUMOR BIOLOGY
- Crosstalk between PKCα and Notch-4 in endocrine-resistant breast cancer cells
- (2013) J Yun et al. Oncogenesis
- The importance of HER2 signaling in the tumor-initiating cell population in aromatase inhibitor-resistant breast cancer
- (2012) Rabia A. Gilani et al. BREAST CANCER RESEARCH AND TREATMENT
- Increased signalling of EGFR and IGF1R and deregulation of PTEN/PI3K/Akt pathway are related with trastuzumab resistance in HER2 breast carcinomas
- (2012) A Gallardo et al. BRITISH JOURNAL OF CANCER
- CXCR4 activation maintains a stem cell population in tamoxifen-resistant breast cancer cells through AhR signalling
- (2012) A Dubrovska et al. BRITISH JOURNAL OF CANCER
- Highly sensitive profiling of CD44+/CD24− breast cancer stem cells by combining global mRNA amplification and next generation sequencing: Evidence for a hyperactive PI3K pathway
- (2012) Olaf Hardt et al. CANCER LETTERS
- RNA aptamers targeting cancer stem cell marker CD133
- (2012) Sarah Shigdar et al. CANCER LETTERS
- Breast cancer stem cells: Obstacles to therapy
- (2012) Matthew Smalley et al. CANCER LETTERS
- Hedgehog Signaling Is a Novel Therapeutic Target in Tamoxifen-Resistant Breast Cancer Aberrantly Activated by PI3K/AKT Pathway
- (2012) B. Ramaswamy et al. CANCER RESEARCH
- Mesenchymal traits are selected along with stem features in breast cancer cells grown as mammospheres
- (2012) Silvia Borgna et al. CELL CYCLE
- Biomarker and Pharmacologic Evaluation of the -Secretase Inhibitor PF-03084014 in Breast Cancer Models
- (2012) C. C. Zhang et al. CLINICAL CANCER RESEARCH
- A phase II study of RO4929097 in metastatic colorectal cancer
- (2012) Jonathan R. Strosberg et al. EUROPEAN JOURNAL OF CANCER
- The opposite effects of doxorubicin on bone marrow stem cells versus breast cancer stem cells depend on glucosylceramide synthase
- (2012) Kaustubh N. Bhinge et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Estrogen Receptor α Signaling Regulates Breast Tumor-initiating Cells by Down-regulating miR-140 Which Targets the Transcription Factor SOX2
- (2012) Yongshu Zhang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Ganglioside GD2 identifies breast cancer stem cells and promotes tumorigenesis
- (2012) Venkata Lokesh Battula et al. JOURNAL OF CLINICAL INVESTIGATION
- Targeting the PI3K/Akt/mTOR Pathway for Breast Cancer Therapy
- (2012) Justin Cidado et al. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
- Expression of Wnt3 Activates Wnt/ -Catenin Pathway and Promotes EMT-like Phenotype in Trastuzumab-Resistant HER2-Overexpressing Breast Cancer Cells
- (2012) Y. Wu et al. MOLECULAR CANCER RESEARCH
- Physiological Roles of Mitochondrial Reactive Oxygen Species
- (2012) Laura A. Sena et al. MOLECULAR CELL
- Activation of an IL6 Inflammatory Loop Mediates Trastuzumab Resistance in HER2+ Breast Cancer by Expanding the Cancer Stem Cell Population
- (2012) Hasan Korkaya et al. MOLECULAR CELL
- Aromatase overexpression induces malignant changes in estrogen receptor α negative MCF-10A cells
- (2012) J Wang et al. ONCOGENE
- Scavenging of CXCL12 by CXCR7 promotes tumor growth and metastasis of CXCR4-positive breast cancer cells
- (2012) K E Luker et al. ONCOGENE
- CD133+ cells with cancer stem cell characteristics associates with vasculogenic mimicry in triple-negative breast cancer
- (2012) T J Liu et al. ONCOGENE
- Immunotoxin targeting CD133+ breast carcinoma cells
- (2012) John R. Ohlfest et al. Drug Delivery and Translational Research
- Autophagy protects breast cancer cells from epirubicin-induced apoptosis and facilitates epirubicin-resistance development
- (2011) Wei-Liang Sun et al. Autophagy
- Inhibition of aldehyde dehydrogenase (ALDH) activity reduces chemotherapy and radiation resistance of stem-like ALDHhiCD44+ human breast cancer cells
- (2011) Alysha K. Croker et al. BREAST CANCER RESEARCH AND TREATMENT
- Hedgehog Overexpression Is Associated with Stromal Interactions and Predicts for Poor Outcome in Breast Cancer
- (2011) S. A. O'Toole et al. CANCER RESEARCH
- The JAK2/STAT3 signaling pathway is required for growth of CD44+CD24– stem cell–like breast cancer cells in human tumors
- (2011) Lauren L.C. Marotta et al. JOURNAL OF CLINICAL INVESTIGATION
- Re-expression of miR-21 contributes to migration and invasion by inducing epithelial-mesenchymal transition consistent with cancer stem cell characteristics in MCF-7 cells
- (2011) Mingli Han et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Understanding the Dual Nature of CD44 in Breast Cancer Progression
- (2011) J. M. V. Louderbough et al. MOLECULAR CANCER RESEARCH
- Everolimus in Postmenopausal Hormone-Receptor–Positive Advanced Breast Cancer
- (2011) José Baselga et al. NEW ENGLAND JOURNAL OF MEDICINE
- DAMP-mediated autophagy contributes to drug resistance
- (2010) Liying Liu et al. Autophagy
- Co-delivery of PDTC and doxorubicin by multifunctional micellar nanoparticles to achieve active targeted drug delivery and overcome multidrug resistance
- (2010) Li Fan et al. BIOMATERIALS
- Multiple molecular mechanisms underlying trastuzumab and lapatinib resistance in JIMT-1 breast cancer cells
- (2010) Katri Köninki et al. CANCER LETTERS
- CD44posCD49fhiCD133/2hi Defines Xenograft-Initiating Cells in Estrogen Receptor–Negative Breast Cancer
- (2010) Matthew J. Meyer et al. CANCER RESEARCH
- Biological and Molecular Heterogeneity of Breast Cancers Correlates with Their Cancer Stem Cell Content
- (2010) Salvatore Pece et al. CELL
- Retinoid signaling regulates breast cancer stem cell differentiation
- (2010) Christophe Ginestier et al. CELL CYCLE
- Sulforaphane, a Dietary Component of Broccoli/Broccoli Sprouts, Inhibits Breast Cancer Stem Cells
- (2010) Y. Li et al. CLINICAL CANCER RESEARCH
- Increased intratumoral androgens in human breast carcinoma following aromatase inhibitor exemestane treatment
- (2010) Kiyoshi Takagi et al. ENDOCRINE-RELATED CANCER
- Hyaluronan-CD44 Interaction Promotes c-Src-mediated Twist Signaling, MicroRNA-10b Expression, and RhoA/RhoC Up-regulation, Leading to Rho-kinase-associated Cytoskeleton Activation and Breast Tumor Cell Invasion
- (2010) Lilly Y. W. Bourguignon et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts
- (2010) Christophe Ginestier et al. JOURNAL OF CLINICAL INVESTIGATION
- Loss of Phosphatase and Tensin Homolog or Phosphoinositol-3 Kinase Activation and Response to Trastuzumab or Lapatinib in Human Epidermal Growth Factor Receptor 2–Overexpressing Locally Advanced Breast Cancers
- (2010) Bhuvanesh Dave et al. JOURNAL OF CLINICAL ONCOLOGY
- Alteration of Topoisomerase II–Alpha Gene in Human Breast Cancer: Association With Responsiveness to Anthracycline-Based Chemotherapy
- (2010) Michael F. Press et al. JOURNAL OF CLINICAL ONCOLOGY
- Aldehyde Dehydrogenase Activity of Breast Cancer Stem Cells Is Primarily Due To Isoform ALDH1A3 and Its Expression Is Predictive of Metastasis
- (2010) Paola Marcato et al. STEM CELLS
- Co-targeting the insulin-like growth factor I receptor enhances growth-inhibitory and pro-apoptotic effects of anti-estrogens in human breast cancer cell lines
- (2009) Ashok K. Chakraborty et al. BREAST CANCER RESEARCH AND TREATMENT
- Adult human mesenchymal stem cells enhance breast tumorigenesis and promote hormone independence
- (2009) Lyndsay V. Rhodes et al. BREAST CANCER RESEARCH AND TREATMENT
- MUC1* is a determinant of trastuzumab (Herceptin) resistance in breast cancer cells
- (2009) Shawn P. Fessler et al. BREAST CANCER RESEARCH AND TREATMENT
- microRNA-205 Regulates HER3 in Human Breast Cancer
- (2009) M. V. Iorio et al. CANCER RESEARCH
- The Emerging Role of EpCAM in Cancer and Stem Cell Signaling
- (2009) M. Munz et al. CANCER RESEARCH
- Tumor-Initiating Cells of HER2-Positive Carcinoma Cell Lines Express the Highest Oncoprotein Levels and Are Sensitive to Trastuzumab
- (2009) A. Magnifico et al. CLINICAL CANCER RESEARCH
- Association of Breast Cancer Stem Cells Identified by Aldehyde Dehydrogenase 1 Expression with Resistance to Sequential Paclitaxel and Epirubicin-Based Chemotherapy for Breast Cancers
- (2009) T. Tanei et al. CLINICAL CANCER RESEARCH
- ABC Transporters, Drug Resistance, and Cancer Stem Cells
- (2009) Michael Dean JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
- NOTCH inhibition and glucocorticoid therapy in T-cell acute lymphoblastic leukemia
- (2009) P J Real et al. LEUKEMIA
- Association of reactive oxygen species levels and radioresistance in cancer stem cells
- (2009) Maximilian Diehn et al. NATURE
- Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
- (2009) C. J. Creighton et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Regulation of Mammary Stem/Progenitor Cells by PTEN/Akt/β-Catenin Signaling
- (2009) Hasan Korkaya et al. PLOS BIOLOGY
- The endocrine prevention of breast cancer
- (2008) Anthony Howell BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- Analysis of ABCG2 expression and side population identifies intrinsic drug efflux in the HCC cell line MHCC-97L and its modulation by Akt signaling
- (2008) Chen Hu et al. CARCINOGENESIS
- Crosstalk between the Estrogen Receptor and the HER Tyrosine Kinase Receptor Family: Molecular Mechanism and Clinical Implications for Endocrine Therapy Resistance
- (2008) Grazia Arpino et al. ENDOCRINE REVIEWS
- High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability
- (2008) Alysha K. Croker et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Crypt stem cells as the cells-of-origin of intestinal cancer
- (2008) Nick Barker et al. NATURE
- MUC1* Mediates the Growth of Human Pluripotent Stem Cells
- (2008) Sherry T. Hikita et al. PLoS One
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now